Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 6Withdrawn 2Unknown 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Lung Neoplasms 4Anus Neoplasms 3Peritoneal Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Carcinoma, Hepatocellular 2Appendiceal Neoplasms 2Stomach Neoplasms 1Recurrence Hepatocellular Carcinoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms 1Mesothelioma 1Liver Metastasis 1Hyperthermia 1Colonic Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma 1Breast Neoplasms 1Anus Diseases 1

Interventions

Sorafenib 46lenvatinib 44apatinib 23sintilimab 22Fluorouracil 21camrelizumab 20Oxaliplatin 17Radiofrequency Ablation 16Radiosurgery 15Hepatectomy 15tislelizumab 14Leucovorin 14Radiotherapy 12Doxorubicin 12toripalimab 11Folfox protocol 10Bevacizumab 10Immune Checkpoint Inhibitors 9Epirubicin 9regorafenib 8Ethiodized Oil 8durvalumab 7donafenib 7anlotinib 7Neoadjuvant Therapy 7pembrolizumab 6entecavir 6Surgical Procedures, Operative 6Nivolumab 6Injections 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Hepatocellular × Mitomycin × Clear all
NCT02301091 2016-04-14

CORTT

Sun Yat-sen University

Phase 3 Unknown
240 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00644020 2008-03-26

Phase â…¡Study of Tyroserleutide for Injection in Hepatocellular Carcinoma(HCC) Patients

Shenzhen Kangzhe Pharmaceutical Co., Ltd.

Unknown
100 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡